News Search Results
Feb 05, 2025, 06:30 ET Bio-Techne Declares Dividend
acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues, the impact of currency
More news about: Bio-Techne Corporation
Feb 05, 2025, 06:30 ET Bio-Techne Releases Second Quarter Fiscal 2025 Results
acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and
More news about: Bio-Techne Corporation
Feb 05, 2025, 05:00 ET From 0 to 100 Trillion: The Rise of Sanyou Bio's Intelligent Molecule Library
vast and advanced technological system that paves a new path for drug discovery. The AI-STAL platform not only witnessed the rapid development of biotechnology, but also foreshadowed a new direction for future biopharmaceutical research. 2015: The Emergence of AI-STAL The year 2015
More news about: Sanyou Bio
Feb 05, 2025, 01:52 ET Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market Transformation - Technavio
DiagnosticTherapeuticEnd-userResearch And Academic InstitutesPharmaceutical And Biotechnology CompaniesCommercialGeographyNorth AmericaEurope
More news about: Technavio
Feb 05, 2025, 00:00 ET China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment
transformative role in drug discovery and clinical applications. CMU and Healthcare System remains at the forefront of healthcare innovation, bridging AI, biotechnology, and clinical practice to redefine the future of medicine. CMU and Healthcare System's pioneering work at the Healthcare Expo Taiwan underscores
More news about: China Medical University Hospital
Feb 04, 2025, 18:15 ET Rakuten Medical Completes Technology Transfer of IR700 Manufacturing and Establishes Exclusive Position in its Supply
DIEGO, Feb. 4, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminox™ platform-based photoimmunotherapy, today announced that it has completed
More news about: Rakuten Medical, Inc.
Feb 04, 2025, 17:46 ET NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Feb 04, 2025, 16:49 ET NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Feb 04, 2025, 16:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
Jefferies downgraded Fortrea, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding. On this news, Fortrea's stock price fell $2.73 per share, or 12.29%, to close at $19.48
More news about: Pomerantz LLP
Feb 04, 2025, 16:05 ET Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in a virtual
More news about: Q32 Bio
Feb 04, 2025, 16:05 ET Nanoscope Therapeutics Announces Presentations at Upcoming Medical Meetings
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal
More news about: Nanoscope Therapeutics
Feb 04, 2025, 16:01 ET AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Feb 04, 2025, 15:55 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC
[Click here for information about joining the class action] Revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the
More news about: Pomerantz LLP
Feb 04, 2025, 11:30 ET Navega Therapeutics Announces CIRM Grant for Treatment of Chronic Pain
Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant from
More news about: Navega Therapeutics
Feb 04, 2025, 10:30 ET Mass Spectrometry Market to Hit USD 9.62 Billion by 2030 with 7.2% CAGR | MarketsandMarkets™
Genomics, Proteomics, and Metabolomics. Based on end users, the mass spectrometry market is segmented into pharmaceutical companies, biotechnology companies, research labs & academic institutes, environmental testing Labs, food and beverage industry, forensic labs, and petrochemical industry.
More news about: MarketsandMarkets
Feb 04, 2025, 08:55 ET NeuroTherapia Announces EMA Approval of its Phase 2 Trial for the Treatment of Alzheimer's Disease
Alzheimer's Association Part the Cloud program. About NeuroTherapia NeuroTherapia, Inc. is a clinical-stage, privately held biotechnology company, spun out of Cleveland Clinic, developing oral, small-molecule drugs to address neuroinflammatory conditions of the central nervous system
More news about: NeuroTherapia, Inc.
Feb 04, 2025, 08:30 ET Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Amit Kumar, Chairman and CEO
More news about: Anixa Biosciences, Inc.
Feb 04, 2025, 08:30 ET Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results
in nine commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Feb 04, 2025, 07:30 ET Soligenix to Present at BIO CEO & Investor Conference
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Feb 04, 2025, 07:00 ET Aktis Oncology Appoints Biotech Industry Veteran Mary Thistle to its Board of Directors
Biotechnology leader brings over 25 years of operational, financial and business development experience to support the Company's growth strategy BOSTON, Feb.
More news about: Aktis Oncology
Feb 04, 2025, 07:00 ET Evolent Health Announces Changes to Board of Directors
Chair of the Compensation Committee. Mr. Springstubb holds a master's degree from Johns Hopkins University in biotechnology and a bachelor's degree in molecular biology and economics from Pomona College. He is a CFA Charterholder and a Certified
More news about: Evolent Health, Inc.
Feb 04, 2025, 06:30 ET Immunic to Participate in Investor and Scientific Conferences in February
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Feb 04, 2025, 06:00 ET As Major Insulin Producers Shift Focus, rBIO Steps Up to Address Potential Shortages
rBIO, a biotechnology company committed to improving insulin access and affordability, is stepping up to fill this gap. Today, the company announced the successful completion
More news about: rBIO
Feb 04, 2025, 03:30 ET Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion
pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion Experienced team with a background in biotechnology and company building led by co-CEO's Dr. Michael Krohn and Lukas LinnigDr.
More news about: Akribion Therapeutics
Feb 04, 2025, 02:03 ET Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market Landscape - Technavio
Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher
More news about: Technavio